Enveric Biosciences Inc (ENVB)
0.84
-0.06
(-6.67%)
USD |
NASDAQ |
May 17, 16:00
0.8228
-0.02
(-2.05%)
After-Hours: 20:00
Enveric Biosciences Cash from Operations (TTM): -14.09M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -14.09M |
| September 30, 2023 | -15.81M |
| June 30, 2023 | -17.62M |
| March 31, 2023 | -17.73M |
| December 31, 2022 | -17.15M |
| September 30, 2022 | -17.75M |
| June 30, 2022 | -15.41M |
| March 31, 2022 | -12.84M |
| December 31, 2021 | -11.46M |
| September 30, 2021 | -9.640M |
| June 30, 2021 | -7.828M |
| March 31, 2021 | -4.758M |
| December 31, 2020 | -3.889M |
| September 30, 2020 | -2.618M |
| June 30, 2020 | -2.224M |
| March 31, 2020 | -3.762M |
| December 31, 2019 | -2.453M |
| September 30, 2019 | -2.477M |
| June 30, 2019 | -3.760M |
| March 31, 2019 | -3.090M |
| December 31, 2018 | -2.566M |
| September 30, 2018 | -2.504M |
| June 30, 2018 | -1.319M |
| March 31, 2018 | -2.362M |
| December 31, 2017 | -2.741M |
| Date | Value |
|---|---|
| September 30, 2017 | -1.506M |
| June 30, 2017 | -4.239M |
| March 31, 2017 | -3.695M |
| December 31, 2016 | -2.704M |
| September 30, 2016 | -6.246M |
| June 30, 2016 | -4.486M |
| March 31, 2016 | -4.168M |
| September 30, 2015 | -4.326M |
| June 30, 2015 | -1.076M |
| March 31, 2015 | -0.0166M |
| December 31, 2014 | -0.0432M |
| September 30, 2014 | -0.0396M |
| June 30, 2014 | -0.0461M |
| March 31, 2014 | -0.0372M |
| December 31, 2013 | -0.0216M |
| September 30, 2013 | -0.025M |
| June 30, 2013 | -0.0248M |
| March 31, 2013 | -0.0249M |
| December 31, 2012 | -0.0249M |
| September 30, 2012 | -0.0259M |
| June 30, 2012 | -0.0245M |
| March 31, 2012 | -0.0255M |
| December 31, 2011 | -0.0303M |
| September 30, 2011 | -0.0286M |
| June 30, 2011 | -0.0638M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-17.75M
Minimum
Sep 2022
-2.224M
Maximum
Jun 2020
-9.646M
Average
-9.640M
Median
Sep 2021
Cash from Operations (TTM) Benchmarks
| Societal CDMO Inc (DELISTED) | -1.005M |
| Seelos Therapeutics Inc | -18.21M |
| Cardiff Oncology Inc | -29.97M |
| BioVie Inc | -41.11M |
| Adial Pharmaceuticals Inc | -6.807M |